Cite
HARVARD Citation
Keam, B. et al. (n.d.). 288 A phase 1 study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors. Journal for immunotherapy of cancer. p. A315. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Keam, B. et al. (n.d.). 288 A phase 1 study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors. Journal for immunotherapy of cancer. p. A315. [Online].